LIP
CRMD icon

Lighthouse Investment Partners’s CorMedix CRMD Stock Holding History

Lighthouse Investment Partners’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,264
Closed -$50.8K – 311
2023
Q1 		$50.8K Sell
12,264
-4,113
-25% -$16.8K ﹤0.01% 251
2022
Q4 		$69.1K Buy
+16,377
New +$57.9K 0.01% 237

Other funds holding CRMD

Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Lighthouse Investment Partners's CRMD Position: Q2 2023 in Review

Lighthouse Investment Partners sold out of CorMedix (CRMD) in Q2 2023, closing a stake of 12,264 shares — an estimated $50.8K sold.

Lighthouse Investment Partners first reported a position in CRMD in Q4 2022 and held it in 2 quarters. The position peaked at $69.1K in Q4 2022. 86 funds tracked by Wall St. Rank hold CRMD as of Q2 2023.

  • Lighthouse Investment Partners reported no remaining CorMedix position as of Q2 2023 after selling out during the quarter.
  • Lighthouse Investment Partners sold 12,264 CorMedix shares in Q2 2023, an estimated $50.8K.
  • Lighthouse Investment Partners first reported a position in CorMedix in Q4 2022 and held it in 2 quarters.
  • Lighthouse Investment Partners's CorMedix position peaked at $69.1K in Q4 2022.
  • 86 funds tracked by Wall St. Rank held CorMedix as of Q2 2023.

Based on Lighthouse Investment Partners's 13F filing for Q2 2023, filed 14 Aug 2023.